Enliven Therapeutics Announces Public Offering Of $200 Mln Of Shares
13/6 12:52
(RTTNews) - Enliven Therapeutics, Inc. (ELVN), a company focused on the discovery and development of small molecule therapeutics, said on Friday that it has commenced an underwritten public offering of $200 million of shares and, in lieu of common stock to investors who so choose...